ACADIA Pharmaceuticals, Inc. To Present At Upcoming Investor Conferences

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders, today announced that it will present at the following investor conferences:

•The Piper Jaffray 25th Annual Healthcare Conference on Tuesday, December 3, 2013, at 10:00 a.m. Eastern Time in New York City.

Help employers find you! Check out all the jobs and post your resume.